| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 178 |
| 1 | ASPIRIN 325 MG | 177 |
| 2 | ASPIRIN 81 MG | 177 |
| 3 | AFLIBERCEPT | 161 |
| 4 | BROLUCIZUMAB | 156 |
| 5 | RANIBIZUMAB | 104 |
| 6 | TRIAMCINOLONE ACETONIDE | 95 |
| 7 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 93 |
| 8 | RIVAROXABAN | 90 |
| 9 | CLOPIDOGREL | 78 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BROLUCIZUMAB | 156 | 0.0428 |
| 1 | AFLIBERCEPT | 161 | 0.0051 |
| 2 | RANIBIZUMAB | 104 | 0.0039 |
| 3 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 93 | 0.0038 |
| 4 | FARICIMAB | 33 | 0.0037 |
| 5 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 25 | 0.0033 |
| 6 | TRIAMCINOLONE ACETONIDE | 95 | 0.0030 |
| 7 | BELATACEPT | 14 | 0.0030 |
| 8 | BARICITINIB | 9 | 0.0029 |
| 9 | BUPIVACAINE | 25 | 0.0027 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 314 |
| 1 | Corticosteroid [EPC] | 287 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 241 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 179 |
| 4 | Factor Xa Inhibitor [EPC] | 142 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 90 |
| 6 | Proton Pump Inhibitor [EPC] | 84 |
| 7 | Vitamin C [EPC] | 79 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 69 |
| 9 | Insulin Analog [EPC] | 65 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Disclosing Agent [EPC] | 1 | 0.0476 |
| 1 | Interleukin-5 Antagonist [EPC] | 10 | 0.0145 |
| 2 | Endoglycosidase [EPC] | 17 | 0.0092 |
| 3 | Selective T Cell Costimulation Blocker [EPC] | 14 | 0.0030 |
| 4 | Antifibrinolytic Agent [EPC] | 21 | 0.0021 |
| 5 | Antiseptic [EPC] | 8 | 0.0018 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 314 | 0.0017 |
| 7 | Provitamin D2 Compound [EPC] | 45 | 0.0015 |
| 8 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 3 | 0.0013 |
| 9 | Photoenhancer [EPC] | 5 | 0.0013 |